Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Earnings for Y-mAbs Therapeutics (YMAB)
Earnings in 2023 (TTM): -$25.68 M
According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings (TTM) are -$25.68 M. In 2022 the company made an earning of -$94.81 M a decrease over its 2021 earnings that were of -$53.43 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Y-mAbs Therapeutics from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$25.68 M | -72.92% |
| 2022 | -$94.81 M | 77.47% |
| 2021 | -$53.43 M | -55.46% |
| 2020 | -$0.12 B | 44.49% |
| 2019 | -$83.01 M | 92.01% |
| 2018 | -$43.23 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 331.52% | 🇺🇸 USA |